Physician

Daniel Francis Zinicola, M.D.

According to 2025 Medicare claims, Daniel Zinicola, M.D. (NPI: 1811991219) practices general practice in the Wilmington, NC market, with the plurality of this provider's patient population coming from Pender, NC. This provider's primary affiliated billing organization is DANIEL F ZINICOLA PC (NPI: 1801855036; TIN: 562109737) and primary practice location at 28457-7871.

Zinicola's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 279 traditional Medicare patients, billed 1,888 HCPCS/CPT codes, and received $76,927 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 13,933 prescription claims across 571 beneficiaries totaling $676,435 in drug costs, led by Eliquis (Apixaban). DME data shows 293 claims. Open Payments data shows 14 records totaling $269. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $191,178 to $76,927. Similarly, Part D prescription costs have declined steadily, from $1,246,774 to $676,435. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $61,249 and ending at $25,082.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	692	5,851	$191,178
2016	644	5,222	$168,409
2017	608	5,101	$160,658
2018	564	4,264	$136,202
2019	475	2,593	$84,212
2020	435	3,187	$108,649
2021	412	3,054	$122,858
2022	352	2,641	$104,493
2023	320	2,213	$93,160
2024	279	1,888	$76,927

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	643	20,186	$1,246,774
2016	634	19,312	$1,157,748
2017	620	18,476	$1,045,754
2018	635	18,153	$1,050,520
2019	583	11,957	$749,340
2020	588	11,504	$661,806
2021	604	13,232	$832,457
2022	573	13,420	$829,498
2023	581	14,282	$849,768
2024	571	13,933	$676,435

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	438	1,509	$72,403
2016	342	1,206	$31,422
2017	312	1,092	$22,962
2018	265	845	$15,074
2019	230	812	$71,760
2020	108	591	$19,791
2021	64	769	$119,720
2022	87	739	$84,127
2023	21	486	$28,692
2024	14	293	$18,774

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	246	587	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	137	264	$58
36415	Insertion of needle into vein for collection of blood sample	234	419	$9
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	127	163	$9
81002	Urinalysis, manual test	59	83	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	101	3,963	$75,948
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	65	2,100	$44,027
Ozempic	Semaglutide	37	1,278	$36,086
Xarelto	Rivaroxaban	44	1,560	$28,503
Janumet	Sitagliptin Phos/Metformin Hcl	15	1,390	$22,985

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	24	$8,017
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	53	$4,675
A7031	Face mask interface, replacement for full face mask, each	N	N/R	14	$1,290
A7030	Full face mask used with positive airway pressure device, each	N	N/R	12	$1,187
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	14	50	$811

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$269	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Francis Zinicola, M.D.?

Tedicare shows public-source Medicare data for Daniel Francis Zinicola, M.D. (NPI 1811991219), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Francis Zinicola, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Francis Zinicola, M.D.?

Daniel Francis Zinicola, M.D. is linked to DANIEL F ZINICOLA PC (billing NPI 1801855036) in the available physician profile data.

Does Daniel Francis Zinicola, M.D. have Open Payments data?

Daniel Francis Zinicola, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.